Back to Search
Start Over
P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELIMINARY SAFETY RESULTS
- Source :
- HemaSphere, Vol 6, Pp 992-993 (2022)
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 6
- Database :
- Directory of Open Access Journals
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2b41e4226d694a59bce8c871eee850a7
- Document Type :
- article
- Full Text :
- https://doi.org/10.1097/01.HS9.0000847276.06711.b7